Helena Tayton-Martin
Founder at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 474 102 $ as of 2024-03-30
Network origin in Helena Tayton-Martin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 42 | |
| Subsidiary | Biotechnology | 25 | |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK
13
| Extinct | Pharmaceuticals: Major | 13 |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.
12
| Subsidiary | Medical/Nursing Services | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Helena Tayton-Martin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| TESARO INC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| BTG | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Founder | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Director of Finance/CFO Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Founder | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| OREXO AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
| New York University | College/University | Masters Business Admin Doctorate Degree | |
| The Pennsylvania State University | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of Toronto | College/University | Doctorate Degree Doctorate Degree | |
| University of Durham | College/University | Undergraduate Degree Undergraduate Degree | |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Chairman Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder Founder Chief Executive Officer Chairman Founder Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | President Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Chief Tech/Sci/R&D Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Chairman | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistics
International
| United States | 27 |
| United Kingdom | 17 |
| Canada | 3 |
| Germany | 2 |
| Sweden | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 17 |
| Commercial Services | 3 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 436 |
| Corporate Officer/Principal | 160 |
| Independent Dir/Board Member | 146 |
| Chairman | 100 |
| Chief Tech/Sci/R&D Officer | 51 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| Frank Armstrong | 41 |
| James Noble | 39 |
| Peter Thompson | 39 |
| Calvin Stiller | 38 |
| Ali Behbahani | 34 |
| J. Kenneth Charles Knowles | 29 |
| John Bell | 27 |
| Catherine Mackey | 24 |
| Barbara Duncan | 22 |
| Charles Sigal | 20 |
| Luke Beshar | 19 |
| Ian Michael Laing | 19 |
| Garry Menzel | 19 |
| Andrew Allen | 18 |
- Stock Market
- Insiders
- Helena Tayton-Martin
- Company connections